Frontlight ResearchEarly access
TerminatedNo phase
Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery
Key facts
- Who runs it
- St. Antonius Hospital
- Where
- Netherlands2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 61 people enrolled
- Started
- 1 Dec 2024
- Ended
- 1 Mar 2025
- Type of study
- Observational
- Treatments tested
- blood leucocyte transcriptomics
- Record updated
- 27 April 2026
- Why it stopped
- Funding stopped
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age >18 years
- Major noncardiac surgery with infection risk >20%
Who cannot take part
- Emergency surgery
- Age <18 years
- Inability to provide informed consent
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Changes in host gene expression may provide additional information to diagnose postoperative infection and improve outcome after surgery. This study aims to validate the early diagnostic performance of specific gene signatures for differentiating infection from non-infected SIRS or uncomplicated postoperative course in blood sampes of adult patients undergoing major noncardiac surgery.
Treatments tested
- blood leucocyte transcriptomics
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 April 2026